{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:38:32Z","timestamp":1761154712496},"reference-count":33,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.vaccine.2004.11.043","type":"journal-article","created":{"date-parts":[[2004,12,9]],"date-time":"2004-12-09T22:58:50Z","timestamp":1102633130000},"page":"2784-2790","source":"Crossref","is-referenced-by-count":16,"title":["Brucella spp. lumazine synthase: a novel antigen delivery system"],"prefix":"10.1016","volume":"23","author":[{"given":"Edda","family":"Sciutto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Toledo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Rosas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Meneses","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Laplagne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Ainciart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacquelynne","family":"Cervantes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gladis","family":"Fragoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando A.","family":"Goldbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.vaccine.2004.11.043_bib1","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0020-7519(03)00162-0","article-title":"Exploiting natural immunity to helminth parasites for the development of veterinary vaccines","volume":"33","author":"Meeusen","year":"2003","journal-title":"Int J Parasitol"},{"issue":"7","key":"10.1016\/j.vaccine.2004.11.043_bib2","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1007\/s00018-003-2185-x","article-title":"What's new in the field of cancer vaccines?","volume":"60","author":"Renno","year":"2003","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2004.11.043_bib3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1568005014606035","article-title":"New approaches for antigen discovery, production and delivery: vaccines for veterinary and human use","volume":"1","author":"Potter","year":"2001","journal-title":"Curr Drug Targets Infect Disord"},{"issue":"6","key":"10.1016\/j.vaccine.2004.11.043_bib4","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/ps\/82.6.870","article-title":"Molecular approaches to disease control","volume":"82","author":"Babiuk","year":"2003","journal-title":"Poult Sci"},{"issue":"4","key":"10.1016\/j.vaccine.2004.11.043_bib5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1515\/BC.2001.071","article-title":"Defined synthetic vaccines","volume":"382","author":"Zauner","year":"2001","journal-title":"Biol Chem"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2004.11.043_bib6","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0923-2508(90)90137-F","article-title":"Recombinant cholera toxin B subunit and gene fusion proteins for oral vaccination","volume":"141","author":"Sanchez","year":"1990","journal-title":"Res Microbiol"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2004.11.043_bib7","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/BF01923462","article-title":"Hsp70: a carrier molecule with built-in adjuvanticity","volume":"50","author":"Del Giudice","year":"1994","journal-title":"Experientia"},{"key":"10.1016\/j.vaccine.2004.11.043_bib8","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0161-5890(99)00136-4","article-title":"Immunostimulatory properties of the Leishmania infantum heat shock proteins HSP70 and HSP83","volume":"36","author":"Rico","year":"1999","journal-title":"Mol Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2004.11.043_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1462-5822.2003.00338.x","article-title":"From toxin to adjuvant: the rational design of a vaccine adjuvant vector, CTA1-DD\/ISCOM","volume":"6","author":"Lycke","year":"2004","journal-title":"Cell Microbiol"},{"issue":"9","key":"10.1016\/j.vaccine.2004.11.043_bib10","doi-asserted-by":"crossref","first-page":"8093","DOI":"10.1074\/jbc.M312035200","article-title":"High order quaternary arrangement confers increased structural stability to Brucella spp. lumazine synthase","volume":"279","author":"Zylberman","year":"2004","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.vaccine.2004.11.043_bib11","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1128\/IAI.71.10.5750-5755.2003","article-title":"Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used","volume":"71","author":"Velikovsky","year":"2003","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2004.11.043_bib12","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1128\/IAI.70.5.2507-2511.2002","article-title":"A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB\/c mice","volume":"70","author":"Velikovsky","year":"2002","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2004.11.043_bib13","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/prot.20248","article-title":"Engineering of a polymeric bacterial protein as a scaffold for the multiple display of peptides","volume":"57","author":"Laplagne","year":"2004","journal-title":"Proteins"},{"issue":"15","key":"10.1016\/j.vaccine.2004.11.043_bib14","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/S1286-4579(00)01336-8","article-title":"Taenia solium disease in humans and pigs: an ancient parasitosis disease rooted in developing countries and emerging as a major health problem of global dimensions","volume":"2","author":"Sciutto","year":"2000","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2004.11.043_bib15","series-title":"Recent Research Developments in Infection and Immunity","first-page":"475","article-title":"Taenia solium cysticercosis of humans and pigs: A review of our contributions and perspectives in the research of its complexities","author":"Sciutto","year":"2003"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2004.11.043_bib16","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0264-410X(01)00249-3","article-title":"Synthetic peptide vaccine against Taenia solium pig cysticercosis: successful vaccination in a controlled field trial in rural Mexico","volume":"20","author":"Huerta","year":"2001","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2004.11.043_bib17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2307\/3284156","article-title":"Cysticercosis: identification and cloning of protective recombinant antigens","volume":"82","author":"Manoutcharian","year":"1996","journal-title":"J Parasitol"},{"issue":"5","key":"10.1016\/j.vaccine.2004.11.043_bib18","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1128\/IAI.67.5.2522-2530.1999","article-title":"Towards a Taenia solium cysticercosis vaccine: an epitope shared by Taenia crassiceps and Taenia solium protects mice against experimental cysticercosis","volume":"67","author":"Toledo","year":"1999","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2004.11.043_bib19","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1128\/IAI.69.3.1766-1773.2001","article-title":"Two epitopes shared by Taenia crassiceps and Taenia solium confer protection against murine T. crassiceps cysticercosis along with a prominent T1 response","volume":"69","author":"Toledo","year":"2001","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2004.11.043_bib20","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0188-4409(02)00376-4","article-title":"New approaches to improve a peptide vaccine against porcine Taenia solium cysticercosis","volume":"33","author":"Sciutto","year":"2002","journal-title":"Arch Med Res"},{"issue":"Pt 6","key":"10.1016\/j.vaccine.2004.11.043_bib21","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1017\/S0031182099004370","article-title":"The systemic immune response of BALB\/c mice infected with larval Taenia crassiceps is a mixed Th1\/Th2-type response","volume":"118","author":"Toenjes","year":"1999","journal-title":"Parasitology"},{"issue":"15","key":"10.1016\/j.vaccine.2004.11.043_bib22","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0264-410X(96)00077-1","article-title":"Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen","volume":"14","author":"Coombes","year":"1996","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2004.11.043_bib23","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1590\/S0100-879X2000000700003","article-title":"Structural, functional and immunological studies on a polymeric bacterial protein","volume":"33","author":"Baldi","year":"2000","journal-title":"Braz J Med Biol Res"},{"issue":"3","key":"10.1016\/j.vaccine.2004.11.043_bib24","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1046\/j.0019-2805.2001.01358.x","article-title":"Diversity in MHC class II antigen presentation","volume":"105","author":"Robinson","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2004.11.043_bib25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1017\/S003118200006515X","article-title":"Genetic control of susceptibility to Taenia crassiceps cysticercosis","volume":"112","author":"Fragoso","year":"1996","journal-title":"Parasitology"},{"issue":"3","key":"10.1016\/j.vaccine.2004.11.043_bib26","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2307\/3284715","article-title":"Taenia crassiceps cysticercosis: humoral immune response and protection elicited by DNA immunization","volume":"84","author":"Rosas","year":"1998","journal-title":"J Parasitol"},{"issue":"1","key":"10.1016\/j.vaccine.2004.11.043_bib27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1645\/0022-3395(2000)086[0067:TCCPEA]2.0.CO;2","article-title":"Taenia crassiceps cysticercosis: protective effect and immune response elicited by DNA immunization","volume":"86","author":"Cruz-Revilla","year":"2000","journal-title":"J Parasitol"},{"issue":"7","key":"10.1016\/j.vaccine.2004.11.043_bib28","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00299-003-0718-2","article-title":"Production of a fusion protein consisting of the enterotoxigenic Escherichia coli heat-labile toxin B subunit and a tuberculosis antigen in Arabidopsis thaliana","volume":"22","author":"Rigano","year":"2004","journal-title":"Plant Cell Rep"},{"issue":"22","key":"10.1016\/j.vaccine.2004.11.043_bib29","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1046\/j.1432-1033.2002.03244.x","article-title":"Hemocyanin from the keyhole limpet Megathura crenulata (KLH) carries a novel type of N-glycans with Gal (beta1-6) Man-motifs","volume":"269","author":"Kurokawa","year":"2002","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.vaccine.2004.11.043_bib30","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0923-2494(98)80144-2","article-title":"The mechanism of cholera toxin adjuvanticity","volume":"148","author":"Lycke","year":"1997","journal-title":"Res Immunol"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2004.11.043_bib31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0928-8244(03)00070-1","article-title":"Construction of recombinant S-layer proteins (rSbsA) and their expression in bacterial ghosts\u2013a delivery system for the nontypeable Haemophilus influenzae antigen Omp26","volume":"37","author":"Riedmann","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2004.11.043_bib32","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1128\/IAI.63.7.2564-2569.1995","article-title":"Influence of preimmunization with tetanus toxoid on immune responses to tetanus toxin fragment C-guest antigen fusions in a Salmonella vaccine carrier","volume":"63","author":"Chabalgoity","year":"1995","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2004.11.043_bib33","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/000163501750541174","article-title":"A revisit of mucosal IgA immunity and oral tolerance","volume":"59","author":"Fujihashi","year":"2001","journal-title":"Acta Odontol Scand"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04008874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04008874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T16:17:21Z","timestamp":1586017041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04008874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":33,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0264410X04008874"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.11.043","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}